186 related articles for article (PubMed ID: 28031260)
1. Immunization with Pneumocystis Cross-Reactive Antigen 1 (Pca1) Protects Mice against Pneumocystis Pneumonia and Generates Antibody to Pneumocystis jirovecii.
Tesini BL; Wright TW; Malone JE; Haidaris CG; Harber M; Sant AJ; Nayak JL; Gigliotti F
Infect Immun; 2017 Apr; 85(4):. PubMed ID: 28031260
[No Abstract] [Full Text] [Related]
2. Immunization with Pneumocystis carinii A12
Tong T; Wang Z; Xu Y; Shen J
BMC Immunol; 2021 Jun; 22(1):40. PubMed ID: 34174820
[TBL] [Abstract][Full Text] [Related]
3. Synthetic p55 tandem DNA vaccine against Pneumocystis carinii in rats.
Fan H; Guo JY; Ma SL; Zhang N; An CL
Microbiol Immunol; 2016 Jun; 60(6):397-406. PubMed ID: 27185490
[TBL] [Abstract][Full Text] [Related]
4. Immunization with recombinant Pneumocystis carinii p55 antigen provides partial protection against infection: characterization of epitope recognition associated with immunization.
Smulian AG; Sullivan DW; Theus SA
Microbes Infect; 2000 Feb; 2(2):127-36. PubMed ID: 10742685
[TBL] [Abstract][Full Text] [Related]
5. Discordant antibody and cellular responses to Pneumocystis major surface glycoprotein variants in mice.
Bishop LR; Helman D; Kovacs JA
BMC Immunol; 2012 Jul; 13():39. PubMed ID: 22788748
[TBL] [Abstract][Full Text] [Related]
6. B cell and antibody responses in mice induced by a putative cell surface peptidase of Pneumocystis murina protect against experimental infection.
Ruan S; Cai Y; Ramsay AJ; Welsh DA; Norris K; Shellito JE
Vaccine; 2017 Jan; 35(4):672-679. PubMed ID: 28012778
[TBL] [Abstract][Full Text] [Related]
7. Active immunization against Pneumocystis carinii with a recombinant P. carinii antigen.
Wells J; Haidaris CG; Wright TW; Gigliotti F
Infect Immun; 2006 Apr; 74(4):2446-8. PubMed ID: 16552076
[TBL] [Abstract][Full Text] [Related]
8. Immunization with Pneumocystis carinii gpA is immunogenic but not protective in a mouse model of P. carinii pneumonia.
Gigliotti F; Wiley JA; Harmsen AG
Infect Immun; 1998 Jul; 66(7):3179-82. PubMed ID: 9632583
[TBL] [Abstract][Full Text] [Related]
9. Active immunization against Pneumocystis carinii with p55-v3 DNA vaccine in rats.
Feng Y; Guo S; Jiang T; Han X; Liu P; Wu T; Luo Y
Can J Microbiol; 2011 May; 57(5):375-81. PubMed ID: 21529125
[TBL] [Abstract][Full Text] [Related]
10. Mechanisms of Surface Antigenic Variation in the Human Pathogenic Fungus
Schmid-Siegert E; Richard S; Luraschi A; Mühlethaler K; Pagni M; Hauser PM
mBio; 2017 Nov; 8(6):. PubMed ID: 29114024
[TBL] [Abstract][Full Text] [Related]
11. Recognition of Pneumocystis carinii antigens by local antibody-secreting cells following resolution of P. carinii pneumonia in mice.
Gigliotti F; Garvy BA; Haidaris CG; Harmsen AG
J Infect Dis; 1998 Jul; 178(1):235-42. PubMed ID: 9652446
[TBL] [Abstract][Full Text] [Related]
12. Vaccine-Induced Immunogenicity and Protection Against Pneumocystis Pneumonia in a Nonhuman Primate Model of HIV and Pneumocystis Coinfection.
Kling HM; Norris KA
J Infect Dis; 2016 May; 213(10):1586-95. PubMed ID: 26823337
[TBL] [Abstract][Full Text] [Related]
13. Overcoming Hurdles to Development of a Vaccine against Pneumocystis jirovecii.
Garvy BA
Infect Immun; 2017 Apr; 85(4):. PubMed ID: 28115507
[TBL] [Abstract][Full Text] [Related]
14. Oral Immunization of Mice with Live Pneumocystis murina Protects against Pneumocystis Pneumonia.
Samuelson DR; de la Rua NM; Charles TP; Ruan S; Taylor CM; Blanchard EE; Luo M; Ramsay AJ; Shellito JE; Welsh DA
J Immunol; 2016 Mar; 196(6):2655-65. PubMed ID: 26864029
[TBL] [Abstract][Full Text] [Related]
15. Intranasal immunization confers protection against murine Pneumocystis carinii lung infection.
Pascale JM; Shaw MM; Durant PJ; Amador AA; Bartlett MS; Smith JW; Gregory RL; McLaughlin GL
Infect Immun; 1999 Feb; 67(2):805-9. PubMed ID: 9916094
[TBL] [Abstract][Full Text] [Related]
16. Serologic responses to pneumocystis proteins in HIV patients with and without Pneumocystis jirovecii pneumonia.
Gingo MR; Lucht L; Daly KR; Djawe K; Palella FJ; Abraham AG; Bream JH; Witt MD; Kingsley LA; Norris KA; Walzer PD; Morris A
J Acquir Immune Defic Syndr; 2011 Jul; 57(3):190-6. PubMed ID: 21372726
[TBL] [Abstract][Full Text] [Related]
17. Characterization of major surface glycoprotein genes of human Pneumocystis carinii and high-level expression of a conserved region.
Mei Q; Turner RE; Sorial V; Klivington D; Angus CW; Kovacs JA
Infect Immun; 1998 Sep; 66(9):4268-73. PubMed ID: 9712777
[TBL] [Abstract][Full Text] [Related]
18. Immunization with
Cobos Jiménez V; Rabacal W; Rayens E; Norris KA
Hum Vaccin Immunother; 2019; 15(9):2075-2080. PubMed ID: 31348719
[TBL] [Abstract][Full Text] [Related]
19. Long-term serologic responses to the Pneumocystis jirovecii major surface glycoprotein in HIV-positive individuals with and without P. jirovecii infection.
Walzer PD; Djawe K; Levin L; Daly KR; Koch J; Kingsley L; Witt M; Golub ET; Bream JH; Taiwo B; Morris A
J Infect Dis; 2009 May; 199(9):1335-44. PubMed ID: 19301979
[TBL] [Abstract][Full Text] [Related]
20. Epitope mapping of a protective monoclonal antibody against Pneumocystis carinii with shared reactivity to Streptococcus pneumoniae surface antigen PspA.
Wells J; Gigliotti F; Simpson-Haidaris PJ; Haidaris CG
Infect Immun; 2004 Mar; 72(3):1548-56. PubMed ID: 14977961
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
